• 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>Surgical Endoscopy >Robotic versus laparoscopic distal pancreatectomy for left-sided pancreatic tumors: a single surgeon's experience of 228 consecutive cases
【24h】

Robotic versus laparoscopic distal pancreatectomy for left-sided pancreatic tumors: a single surgeon's experience of 228 consecutive cases

机译：左侧胰腺肿瘤的机器人与腹腔镜远端胰腺切除术：连续228例外科医生的经验

获取原文
获取原文并翻译 | 示例
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

Background Laparoscopic distal pancreatectomy (LDP) has gained popularity for the treatment of left-sided pancreatic tumors. Robotic systems represent the most recent advancement in minimally invasive surgical treatment for such tumors. Theoretically, robotic systems are considered to have several advantages over laparoscopic systems. However, there have been few studies comparing both systems in the treatment of distal pancreatectomy. We compared perioperative and oncological outcomes between the two treatment modalities. Methods A retrospective analysis was conducted of all consecutive minimally invasive distal pancreatectomy cases performed by a single surgeon at a high-volume center between January 2015 and December 2017. Results The analysis included 228 consecutive patients (LDP, n = 182; Robotic-assisted laparoscopic distal pancreatectomy [R-LDP], n = 46). Operative time was significantly longer in the R-LDP group than in the LDP group (166.4 vs. 140.7 min; p = 0.001). In a subgroup analysis of patients who underwent the spleen-preserving approach, the spleen preservation rate associated with R-LDP was significantly higher than that associated with LDP (96.8% vs. 82.5%; p = 0.02). In another subgroup analysis of patients with pancreatic cancer, there were no significant differences in median overall and disease-free survival between the two groups. Conclusions R-LDP is a safe and feasible approach with perioperative and oncological outcomes comparable to those of LDP. R-LDP offers an added technical advantage that enables the surgeon to perform a complex procedure with good ergonomic comfort.
机译：背景技术腹腔镜远端胰蛋白切除术（LDP）对左侧胰腺肿瘤的治疗具有普及。机器人系统代表了对这种肿瘤的微创手术治疗最新的促进。理论上，机器人系统被认为具有优于腹腔镜系统的若干优点。然而，在远端胰腺切除术治疗中，甚至几乎没有研究。我们在两种治疗方式之间进行了围手术期和肿瘤学结果。方法对2015年1月至2017年12月的大容量中心进行的所有连续微创远端胰腺切除术病例进行了回顾性分析。结果分析包括228名连续患者（LDP，N = 182;机器人辅助腹腔镜远端胰腺切除术[R-LDP]，n = 46）。在R-LDP组中的操作时间比LDP组在R-LDP组中显着更长（166.4与140.7分钟; p = 0.001）。在接受脾脏保存方法的患者的亚组分析中，与R-LDP相关的脾脏保存率明显高于LDP（96.8％与82.5％; P = 0.02）。在胰腺癌患者的另一个亚组分析中，两组之间的中位数和无病生存率没​​有显着差异。结论R-LDP是一种安全可行的方法，具有与LDP的围手术期和肿瘤的结果。 R-LDP提供了一个额外的技术优势，使外科医生能够进行具有良好符合人体工程学舒适性的复杂程序。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号